TY - JOUR AU - Verma, Saurav AU - Vadlamani, Surya Prakash AU - Shamim, Shamim Ahmed AU - Barwad, Adarsh AU - Rastogi, Sameer AU - Raj, S. T. Arun PY - 2020 DA - 2020/12/12 TI - Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma JO - Clinical Sarcoma Research SP - 28 VL - 10 IS - 1 AB - Chordoma is a rare, slow growing and locally aggressive mesenchymal neoplasm with uncommon distant metastases. It is a chemo-resistant disease with surgery and radiotherapy being the mainstay in treatment of localized disease. In advanced disease imatinib has a role. We report a case of metastatic sacral chordoma with symptomatic and radiological response to erlotinib post-progression on imatinib. SN - 2045-3329 UR - https://doi.org/10.1186/s13569-020-00149-1 DO - 10.1186/s13569-020-00149-1 ID - Verma2020 ER -